Main publications

Queille-Roussel C, Hoffmann V et al. Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test. Clin Drug Investig. 2012 Sep 1;32(9):613-9.

Guéniche A, Cathelineau AC et al. Vitreoscilla filiformis biomass improves seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1014-5.

Kienzler JL, Queille-Roussel C et al. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses. Curr Med Res Opin. 2007 Jun;23(6):1293-302.

Duteil L, Queille-Roussel C et al. A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers. Clin Exp Dermatol. 2002 Jun;27(4):314-8.

Duteil I, Queille-Roussel C et al. Highprotective effect of a broad-spectrum sunscreen against tetracycline phototoxicity. Eur J Dermatol. 2002 Jul-Aug;12(4):X-XI.

Queille-Roussel C, Duteil L et al. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. Eur J Dermatol. 2001 May-Jun;11(3):219-24.

Queille-Roussel C, Paul C et al. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol. 2001 Mar;144(3):507-13.

Queille-Roussel C, Graeber M et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis. 2000 Jun;42(6):349-50.

Phase 1 Studies

1.      Clinical trials in dermatology. The phase I trials.
J.Czernielewski, C. Queille-Roussel, L. Duteil, M. Verschoore, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne
Thérapie (1991) 46: 183-187

 

2.      Les essais cliniques en dermatologie : Partie II : Evaluation de la tolérance et de l'efficacité d'un antiacnéique topique
M. Verschoore, M. Poncet, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne, J.Czernielewski,
Thérapie (1991) 46: 189-91

 

3.      Clinical trials in dermatology. Evaluation of the tolerability and efficacy inflammatory treatment in atopic dermatitis.
C. Queille-Roussel, C. Dahan, L. Duteil, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne, J.Czernielewski,
Thérapie (1991) 46:193-196

 

4.      Clinical trials in dermatology. Evaluation of the tolerability and efficacy antipsoriatic treatment.
C. Dahan, C. Queille-Roussel, M. Verschoore, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne,  J.Czernielewski
Thérapie (1991) 46:197-200

 

5.      Clinical trials in dermatology. Evaluation of the tolerability and efficacy agent in the treatment of superficial mycoses.
C. Queille-Roussel, C. Dahan, M. Poncet, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne, J.Czernielewski
Thérapie (1991) 46:201-204

 

6.      Clinical trials in dermatology. Statistical support.
 L. Duteil, C. Dahan, M. Poncet, H. Schaefer, J. Revuz, Y. De Prost, J.C. Guillaume, J.P. Ortonne, J.Czernielewski
T
hérapie. 1991 May-Jun;46(3):205-9